ClinicalTrials.gov
public full text
Public Domain
Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery
The dermal substitute NEVELIA® has received CE marking in July 9, 2013. Its use in the NEVAL protocol will be in accordance with its leaflet, i.e. for the treatment of burns or in case of reconstructive plastic surgery. The matric implantation will be followed by autologous skin grafting when the neodermis formation will be observed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PDL and Fractional Photothermolysis for Postsurgical Scars#864611
- Electrocautery for Safe Skin Incision#454139
- Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™#911480
- Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery#833856
- Procedimiento de verificación analítica basado en CLSI EP15-A3 y construcción de carta de control para la determinación de cistatina C en el sistema de Nefelometría Atellica® NEPH630 realizado en el Laboratorio Clínico Diagnomed S.A.#680317
Record · ID 1073865
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive